1. Academic Validation
  2. SCH00013, a novel Ca(2+) sensitizer with positive inotropic and no chronotropic action in heart failure

SCH00013, a novel Ca(2+) sensitizer with positive inotropic and no chronotropic action in heart failure

  • J Pharmacol Sci. 2005 Jan;97(1):53-60. doi: 10.1254/jphs.fp0040654.
Naoto Tadano 1 Sachio Morimoto Akira Yoshimura Makoto Miura Kimitomo Yoshioka Mitsuo Sakato Iwao Ohtsuki Yoshikazu Miwa Fumi Takahashi-Yanaga Toshiyuki Sasaguri
Affiliations

Affiliation

  • 1 Department of Clinical Pharmacology, Graduate School of Medical Sciences, Kyushu University, Fukuoka, Japan.
Abstract

We investigated the effects of the agent SCH00013 on CA(2+)-induced force generation in rabbit skinned cardiac muscle fibers and in vivo cardiac function in high-pacing-induced heart failure dogs. The CA(2+)-induced force generation in skinned cardiac muscle fibers was determined at pH 6.2 - 7.4, and SCH00013 was found to have a significant CA(2+) sensitizing effect at pH 7.2 to 7.4. There was no significant difference in the CA(2+) sensitizing action between the enantiomers of SCH00013. The CA(2+) sensitizing effect of SCH00013 was dependent on the sarcomere length, being significant only at a long sarcomere length. SCH00013 elicited a positive inotropic effect at more than 0.3 and 1 mg/kg, i.v. in normal and heart failure dogs, respectively, with no chronotropic action. These results strongly suggested that SCH00013 is a novel CA(2+) sensitizer that elicits a positive inotropic and no chronotropic effect in heart failure, probably through enhancing the Frank-Starling mechanism.

Figures
Products